The Food and Drug Administration held a public meeting on August 15, 2016, to take public statements on the reauthorization of the Prescription Drug User Fee Act (PDUFA). National Health Council Chief Executive Officer Marc Boutin presented on behalf of the nation's leading patient advocacy organizations. His video was from the FDA webcast of the hearing
Marc Boutin, CEO, interviewed by Paul Simms, Chairman of eyeforpharma, regarding engaging patients in drug development.
An interview with David Meeker, Executive Vice President, Head Sanofi-Genzyme.
Dr. Francis Collins, Director, National Institutes of Health, reviewed the top five trends shaping the health care landscape and the importance of the NIH and patient organizations working together.
An interview with Eric Letsinger, Founder, Quantified Ventures on emerging issues in the health community and ways to strengthen patient advocacy organizations.
An interview with Peter Segall, General Manager, Edelman.
An interview with Jason Saul, Founder and CEO, Mission Measurement and Adjunct Lecturer, Kellogg School of Management, Northwestern University.
NHC Senior Vice President of Strategic Initiatives, Eleanor Perfetto, discusses her research at the University of Maryland on how patients with rare diseases can become empowered through involvement in patient-centered research.
NHC CEO Marc Boutin participates in a roundtable discussion on value-based medicine and designing a patient-centered health care system during a forum hosted by The Hill.
NHC CEO Marc Boutin discusses the importance of patient-centeredness in the health care system during a forum hosted by The Hill.
NHC CEO Marc Boutin was one of the presenters on a panel of patient advocates speaking to the Board of Directors of the Patient-Centered Outcomes Research Institute. He discussed the role the NHC played in creating PCORI and hte patient community's ongoing support for the Institute's work to advance patient-centered outcomes research.
NHC CEO Marc Boutin was a panelist during a FDA public meeting in July 2015. The panel outlined the FDA's goals in the reauthorization process.
U.S. Secretary of Health and Human Services, Sylvia Burwell, brought together stakeholders from throughout the health community on November 20, 2015, to discuss how to address the complex problem of balancing access to medications and encouraging innovation. NHC CEO Marc Boutin participated in a panel discussing the issues from the patient and consumer perspectives.
NHC CEO Marc Boutin, in an interview with Patient Focused Medicines Development, states, "We need treatments that reflect values that are important to patients."
NHC Assistant Vice President of Government Affairs, Eric Gascho, participated in a webinar on how to getmental health and substance use insurance coverage in the health insurance exchanges. A recording of the webinar is available online.
NHC CEO Marc Boutin participated in a panel on the value of PCOR in the real world during the 2015 PCORI Annual Meeting. A recording of the panel discussion is available online.
NHC CEO Marc Boutin participated on a panel discussing the challenges and opportunities in turning new evidence into clinical practice during the 2015 PCORI Annual Meeting. A recording of the panel discussion is available online.
NHC CEO Marc Boutin discusses how asking patients about what is going on in their lives could inform treatment, and how the current health care system in the United States makes this type of patient-physician relationship difficult.
NHC CEO Marc Boutin participated on a panel during Research!America's 2015 National Health Research Forum. The panel focused on the challenge and promise of regulatory science.
National Health Council CEO Marc Boutin participated on a panel discussing the Bipartisan Policy Council's report on Advancing Medical Innovation for a Healthier America and the need to incorporate the patient voice into every stage of the continuum to create new and better treatments for people with chronic conditions.